{"id":742694,"date":"2023-03-27T07:05:49","date_gmt":"2023-03-27T11:05:49","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/igm-biosciences-to-announce-fourth-quarter-and-full-year-2022-financial-results-and-host-conference-call-and-webcast-on-march-30-2023\/"},"modified":"2023-03-27T07:05:49","modified_gmt":"2023-03-27T11:05:49","slug":"igm-biosciences-to-announce-fourth-quarter-and-full-year-2022-financial-results-and-host-conference-call-and-webcast-on-march-30-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/igm-biosciences-to-announce-fourth-quarter-and-full-year-2022-financial-results-and-host-conference-call-and-webcast-on-march-30-2023\/","title":{"rendered":"IGM Biosciences to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call and Webcast on March 30, 2023"},"content":{"rendered":"
\n

MOUNTAIN VIEW, Calif., March 27, 2023 (GLOBE NEWSWIRE) — IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced that it will report its fourth quarter and full year 2022 financial results on Thursday, March 30, 2023.<\/p>\n

In connection with the earnings release, IGM\u2019s management team will host a live conference call and webcast at 4:30 p.m. ET on Thursday, March 30, 2023, to discuss the Company\u2019s financial results and provide a corporate update. The webcast can be accessed by clicking the link: https:\/\/edge.media-server.com\/mmc\/p\/ud83kix8<\/a> and will be available on the \u201cEvents and Presentations\u201d page in the \u201cInvestors\u201d section of the Company\u2019s website.<\/p>\n

\n About IGM Biosciences, Inc.<\/strong>
\n
IGM Biosciences is a clinical-stage biotechnology company committed to developing and delivering a new class of medicines to treat patients with cancer, infectious diseases and autoimmune and inflammatory diseases. The Company\u2019s pipeline of clinical and preclinical assets is based on the IgM antibody, which has 10 binding sites compared to conventional IgG antibodies with only 2 binding sites. The Company also has an exclusive worldwide collaboration agreement with Sanofi to create, develop, manufacture, and commercialize IgM antibody agonists against oncology and immunology and inflammation targets. For more information, please visit www.igmbio.com<\/a>.<\/p>\n

\n Contact<\/strong>
\n
Argot Partners
David Pitts
212-600-1902
igmbio@argotpartners.com<\/a><\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

MOUNTAIN VIEW, Calif., March 27, 2023 (GLOBE NEWSWIRE) — IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced that it will report its fourth quarter and full year 2022 financial results on Thursday, March 30, 2023. In connection with the earnings release, IGM\u2019s management team will host a live conference call and webcast at 4:30 p.m. ET on Thursday, March 30, 2023, to discuss the Company\u2019s financial results and provide a corporate update. The webcast can be accessed by clicking the link: https:\/\/edge.media-server.com\/mmc\/p\/ud83kix8 and will be available on the \u201cEvents and Presentations\u201d page in the \u201cInvestors\u201d section of the Company\u2019s website. About IGM Biosciences, Inc. IGM Biosciences is a clinical-stage … <\/p>\n

Continue reading “IGM Biosciences to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call and Webcast on March 30, 2023”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-742694","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nIGM Biosciences to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call and Webcast on March 30, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/igm-biosciences-to-announce-fourth-quarter-and-full-year-2022-financial-results-and-host-conference-call-and-webcast-on-march-30-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IGM Biosciences to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call and Webcast on March 30, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MOUNTAIN VIEW, Calif., March 27, 2023 (GLOBE NEWSWIRE) — IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced that it will report its fourth quarter and full year 2022 financial results on Thursday, March 30, 2023. In connection with the earnings release, IGM\u2019s management team will host a live conference call and webcast at 4:30 p.m. ET on Thursday, March 30, 2023, to discuss the Company\u2019s financial results and provide a corporate update. The webcast can be accessed by clicking the link: https:\/\/edge.media-server.com\/mmc\/p\/ud83kix8 and will be available on the \u201cEvents and Presentations\u201d page in the \u201cInvestors\u201d section of the Company\u2019s website. About IGM Biosciences, Inc. IGM Biosciences is a clinical-stage … Continue reading "IGM Biosciences to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call and Webcast on March 30, 2023"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/igm-biosciences-to-announce-fourth-quarter-and-full-year-2022-financial-results-and-host-conference-call-and-webcast-on-march-30-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-27T11:05:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NTI5MSM1NDgxMzI3IzIxODgyNDk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/igm-biosciences-to-announce-fourth-quarter-and-full-year-2022-financial-results-and-host-conference-call-and-webcast-on-march-30-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/igm-biosciences-to-announce-fourth-quarter-and-full-year-2022-financial-results-and-host-conference-call-and-webcast-on-march-30-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"IGM Biosciences to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call and Webcast on March 30, 2023\",\"datePublished\":\"2023-03-27T11:05:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/igm-biosciences-to-announce-fourth-quarter-and-full-year-2022-financial-results-and-host-conference-call-and-webcast-on-march-30-2023\\\/\"},\"wordCount\":238,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/igm-biosciences-to-announce-fourth-quarter-and-full-year-2022-financial-results-and-host-conference-call-and-webcast-on-march-30-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5NTI5MSM1NDgxMzI3IzIxODgyNDk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/igm-biosciences-to-announce-fourth-quarter-and-full-year-2022-financial-results-and-host-conference-call-and-webcast-on-march-30-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/igm-biosciences-to-announce-fourth-quarter-and-full-year-2022-financial-results-and-host-conference-call-and-webcast-on-march-30-2023\\\/\",\"name\":\"IGM Biosciences to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call and Webcast on March 30, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/igm-biosciences-to-announce-fourth-quarter-and-full-year-2022-financial-results-and-host-conference-call-and-webcast-on-march-30-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/igm-biosciences-to-announce-fourth-quarter-and-full-year-2022-financial-results-and-host-conference-call-and-webcast-on-march-30-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5NTI5MSM1NDgxMzI3IzIxODgyNDk=\",\"datePublished\":\"2023-03-27T11:05:49+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/igm-biosciences-to-announce-fourth-quarter-and-full-year-2022-financial-results-and-host-conference-call-and-webcast-on-march-30-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/igm-biosciences-to-announce-fourth-quarter-and-full-year-2022-financial-results-and-host-conference-call-and-webcast-on-march-30-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/igm-biosciences-to-announce-fourth-quarter-and-full-year-2022-financial-results-and-host-conference-call-and-webcast-on-march-30-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5NTI5MSM1NDgxMzI3IzIxODgyNDk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5NTI5MSM1NDgxMzI3IzIxODgyNDk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/igm-biosciences-to-announce-fourth-quarter-and-full-year-2022-financial-results-and-host-conference-call-and-webcast-on-march-30-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IGM Biosciences to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call and Webcast on March 30, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IGM Biosciences to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call and Webcast on March 30, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/igm-biosciences-to-announce-fourth-quarter-and-full-year-2022-financial-results-and-host-conference-call-and-webcast-on-march-30-2023\/","og_locale":"en_US","og_type":"article","og_title":"IGM Biosciences to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call and Webcast on March 30, 2023 - Market Newsdesk","og_description":"MOUNTAIN VIEW, Calif., March 27, 2023 (GLOBE NEWSWIRE) — IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced that it will report its fourth quarter and full year 2022 financial results on Thursday, March 30, 2023. In connection with the earnings release, IGM\u2019s management team will host a live conference call and webcast at 4:30 p.m. ET on Thursday, March 30, 2023, to discuss the Company\u2019s financial results and provide a corporate update. The webcast can be accessed by clicking the link: https:\/\/edge.media-server.com\/mmc\/p\/ud83kix8 and will be available on the \u201cEvents and Presentations\u201d page in the \u201cInvestors\u201d section of the Company\u2019s website. About IGM Biosciences, Inc. IGM Biosciences is a clinical-stage … Continue reading \"IGM Biosciences to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call and Webcast on March 30, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/igm-biosciences-to-announce-fourth-quarter-and-full-year-2022-financial-results-and-host-conference-call-and-webcast-on-march-30-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-03-27T11:05:49+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NTI5MSM1NDgxMzI3IzIxODgyNDk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/igm-biosciences-to-announce-fourth-quarter-and-full-year-2022-financial-results-and-host-conference-call-and-webcast-on-march-30-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/igm-biosciences-to-announce-fourth-quarter-and-full-year-2022-financial-results-and-host-conference-call-and-webcast-on-march-30-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"IGM Biosciences to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call and Webcast on March 30, 2023","datePublished":"2023-03-27T11:05:49+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/igm-biosciences-to-announce-fourth-quarter-and-full-year-2022-financial-results-and-host-conference-call-and-webcast-on-march-30-2023\/"},"wordCount":238,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/igm-biosciences-to-announce-fourth-quarter-and-full-year-2022-financial-results-and-host-conference-call-and-webcast-on-march-30-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NTI5MSM1NDgxMzI3IzIxODgyNDk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/igm-biosciences-to-announce-fourth-quarter-and-full-year-2022-financial-results-and-host-conference-call-and-webcast-on-march-30-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/igm-biosciences-to-announce-fourth-quarter-and-full-year-2022-financial-results-and-host-conference-call-and-webcast-on-march-30-2023\/","name":"IGM Biosciences to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call and Webcast on March 30, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/igm-biosciences-to-announce-fourth-quarter-and-full-year-2022-financial-results-and-host-conference-call-and-webcast-on-march-30-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/igm-biosciences-to-announce-fourth-quarter-and-full-year-2022-financial-results-and-host-conference-call-and-webcast-on-march-30-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NTI5MSM1NDgxMzI3IzIxODgyNDk=","datePublished":"2023-03-27T11:05:49+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/igm-biosciences-to-announce-fourth-quarter-and-full-year-2022-financial-results-and-host-conference-call-and-webcast-on-march-30-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/igm-biosciences-to-announce-fourth-quarter-and-full-year-2022-financial-results-and-host-conference-call-and-webcast-on-march-30-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/igm-biosciences-to-announce-fourth-quarter-and-full-year-2022-financial-results-and-host-conference-call-and-webcast-on-march-30-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NTI5MSM1NDgxMzI3IzIxODgyNDk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NTI5MSM1NDgxMzI3IzIxODgyNDk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/igm-biosciences-to-announce-fourth-quarter-and-full-year-2022-financial-results-and-host-conference-call-and-webcast-on-march-30-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"IGM Biosciences to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call and Webcast on March 30, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/742694","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=742694"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/742694\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=742694"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=742694"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=742694"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}